4
Feb
Medications
Understanding IBD Biologics: Anti-TNF, Anti-Integrin & IL-12/23 Inhibitors Explained
IBD biologics like anti-TNF, anti-integrin, and IL-12/23 inhibitors target immune pathways to treat Crohn's and ulcerative colitis. Learn how they work, compare effectiveness, side effects, and recent FDA approvals like risankizumab for UC in 2024. Real patient experiences and cost insights included.
Caden Aldridge